Last reviewed · How we verify
GDC-0853 and itraconazole — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
GDC-0853 and itraconazole (GDC-0853 and itraconazole) — Genentech, Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| GDC-0853 and itraconazole TARGET | GDC-0853 and itraconazole | Genentech, Inc. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- GDC-0853 and itraconazole CI watch — RSS
- GDC-0853 and itraconazole CI watch — Atom
- GDC-0853 and itraconazole CI watch — JSON
- GDC-0853 and itraconazole alone — RSS
Cite this brief
Drug Landscape (2026). GDC-0853 and itraconazole — Competitive Intelligence Brief. https://druglandscape.com/ci/gdc-0853-and-itraconazole. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab